According to new findings from University of Michigan scientists, eating too much fat could seriously hobble your immune ...

Background The neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammation associated with adverse ...

As reported by Medscape Medical News, research presented at the 2024 APA annual meeting showed that the risk for moderate and severe neutropenia is low to minimal in people taking clozapine for ...

Posters presented at the 2025 American Academy of Dermatology Annual Meeting found bimekizumab to have benefits beyond safety ...

FDG PET-derived imaging biomarkers of airway inflammation and their clinical associations in patients with non-small cell ...

While initial study results suggest Beam's technology can correct alpha-1 antitrypsin deficiency's genetic roots, shares fell ...

Beam Therapeutics (BEAM) announced initial safety and efficacy data from its Phase 1/2 trial of BEAM-302, establishing clinical ...

During a live event, Catherine J. Lee, MD, MS, discussed the efficacy and safety results of various trials of approved agents ...

Late-breaking results presented at AAD show 80% or more scalp hair coverage at Week 36 in 42.4% of adolescents receiving baricitinib 4 mg INDIANAPOLIS /PRNewswire/ -- Late-breaking results from Eli ...

Q4 2024 Earnings Call Transcript March 6, 2025 CytomX Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.22, expectations were $-0.23. Operator: Good afternoon, everyone. Thank you for ...

However, EpCAM is also expressed at moderate to high levels in normal ... the anticipated GI toxicities and cytopenias such as neutropenia and anemia that's are commonly associated with topo ...

A study published in November in the American Journal of Clinical Pathology that Emerson co-authored validated the analyzer against the Sysmex XN Automated Hematology System and found that CytoChip's ...